Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine for clozapine-induced nocturnal sialorrhoea (pilot crossover)
2009-016300-23Phase 4Completed
- Sponsor
- King's College London
- Start
- Nov 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of scopolamine in hypersalivation (2 arms), sponsored by King's College London. Primary endpoint: Toronto Nocturnal Hypersalivation Scale score. Started Nov 2009; status: completed.
02
Drugs
scopolamine
03
Conditions
hypersalivation
Beyond the preview
Go deeper on 2009-016300-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016300-23.